Infusion-related reactions and premedication patterns in ublituximab-treated multiple sclerosis patients: a multicenter real-world study.

Nourelden AZ, Scott PR, Hooshmand SI, Mazur I, Mada F, Ash T, Patel N, Rube J, Yarraguntla K, Deluca C, et al.

Front Neurol. 2026; 17:1840196. PMID: 42534927. Abstract